The main prognostic factors associated with BC are the number of involved lymph nodes, tumor size, histological grade, and hormone receptor status, while the treatment decision is based on both clinical and molecular characteristics of the tumor [2]. The gene discussed is NR4A1; the disease is neoplasm.